Abiopharma

FDA approve CALCIUM CHLORIDE

FDA approve EXEMESTANE

SpringWorks Therapeutics (SWTX) was removed from the list of traded instruments on NASDAQ exchange

Inozyme Pharma Inc. (INZY) was removed from the list of traded instruments on NASDAQ exchange

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Inozyme Pharma, Inc. - Common Stock.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Inozyme Pharma, Inc. - Common Stock.

NASDAQ symbol attribute type Security_Name was changed. Previous value: Inozyme Pharma, Inc. - Common Stock. New value: Inozyme Pharma, Inc. - Common Stock.

NASDAQ symbol attribute type Security_Name was changed. Previous value: SpringWorks Therapeutics, Inc. - common stock. New value: SpringWorks Therapeutics, Inc. - common stock.

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: SpringWorks Therapeutics, Inc. - common stock.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: SpringWorks Therapeutics, Inc. - common stock.

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

ArriVent Announces Pricing of $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Intel Core Ultra 9: Arrow Lake’s AI Powerhouse and Efficiency Champion

The Latest on XMP: Next-Gen Memory Overclocking & AI Boosts

Night Has Fallen: Everything We Know About the Fourth Mike Banning Thriller